Welcome to our dedicated page for Chimera Investment SEC filings (Ticker: CIMO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Chimera Investment Corporation 9.250% Senior Notes due 2029 (CIMO) provides access to regulatory documents filed by Chimera Investment Corporation as the issuer. In its Form 8-K filings, the company lists the 9.250% Senior Notes due 2029 with the trading symbol CIMO among the securities registered under Section 12(b) of the Exchange Act on the New York Stock Exchange.
Chimera Investment Corporation uses SEC filings to report a range of events that are relevant to holders of its securities, including CIMO. The available Form 8-K filings show disclosures about cash dividends on common and preferred stock, quarterly financial results, and the creation of direct financial obligations through new senior note issuances. For example, one Form 8-K describes the public offering of 8.875% Senior Notes due 2030 under an existing indenture, detailing interest rate, maturity, ranking as senior unsecured obligations, and use of proceeds.
On this page, users can review filings such as current reports on Form 8-K, registration statements referenced for senior note offerings, and related exhibits including indentures, supplemental indentures, and forms of notes. These documents explain how Chimera Investment Corporation structures and ranks its senior notes, including the framework that also covers the 9.250% Senior Notes due 2029.
Stock Titan enhances these filings with AI-powered summaries that highlight key terms, events of default language, ranking descriptions, and use-of-proceeds disclosures drawn from the underlying documents. Real-time updates from EDGAR ensure that new filings from Chimera Investment Corporation are added as they become available, and users can quickly locate information relevant to CIMO within the broader set of the issuer’s regulatory reports.
Chimera Investment Corporation reported a net loss of $43.9 million for the quarter ended March 31, 2026, versus net income of $167.3 million a year earlier. Net interest income rose to $75.0 million, but large unrealized and realized losses on financial instruments and debt extinguishment pushed results negative.
Net income (loss) available to common shareholders was $(65.0) million, or $(0.78) per basic share, compared with $145.9 million or $1.79 per share in 2025. Total assets were $16.0 billion, stockholders’ equity was $2.46 billion, and common shares outstanding were 83.6 million as of April 30, 2026.
Chimera Investment Corporation reported a net loss of $43.9 million for the quarter ended March 31, 2026, versus net income of $167.3 million a year earlier. Net interest income rose to $75.0 million, but large unrealized and realized losses on financial instruments and debt extinguishment pushed results negative.
Net income (loss) available to common shareholders was $(65.0) million, or $(0.78) per basic share, compared with $145.9 million or $1.79 per share in 2025. Total assets were $16.0 billion, stockholders’ equity was $2.46 billion, and common shares outstanding were 83.6 million as of April 30, 2026.
Chimera Investment Corporation announced second quarter 2026 cash dividends on all four series of its preferred stock. The Board declared $0.50 per share for the 8.00% Series A Cumulative Redeemable Preferred Stock.
For the fixed-to-floating series, Chimera declared $0.6095 per share on the 8.00% Series B, $0.5561 per share on the 7.75% Series C, and $0.5967 per share on the 8.00% Series D preferred stock. These dividends, reflecting annualized rates tied to three-month CME Term SOFR plus stated spreads, are payable on June 30, 2026 to shareholders of record on June 1, 2026, with an ex-dividend date of June 1, 2026.
Chimera Investment Corporation announced second quarter 2026 cash dividends on all four series of its preferred stock. The Board declared $0.50 per share for the 8.00% Series A Cumulative Redeemable Preferred Stock.
For the fixed-to-floating series, Chimera declared $0.6095 per share on the 8.00% Series B, $0.5561 per share on the 7.75% Series C, and $0.5967 per share on the 8.00% Series D preferred stock. These dividends, reflecting annualized rates tied to three-month CME Term SOFR plus stated spreads, are payable on June 30, 2026 to shareholders of record on June 1, 2026, with an ex-dividend date of June 1, 2026.
Chimera Investment Corporation reported Q1 2026 results with GAAP net loss available to common shareholders of $65 million, or $(0.78) per diluted share, but non-GAAP earnings available for distribution of $46 million, or $0.54 per diluted common share, which supported the quarterly dividend of $0.45.
Book value per common share was $18.34, down from $19.70, with management attributing nearly two-thirds of the decline to portfolio optimization, including redeeming $1.0 billion of securitized debt at par and selling $1.2 billion of seasoned reperforming loans, releasing about $195 million for reinvestment into Agency RMBS.
The Residential Origination segment produced net income of $8 million, EBTDA of $11 million and funded production volume of $884 million, up 39% versus Q1 2025. Company-wide, earnings available for distribution were $45.8 million, total assets were $15,979,379 (dollars in thousands), GAAP leverage was 5.2:1 and recourse leverage was 2.9:1.
Chimera Investment Corporation reported Q1 2026 results with GAAP net loss available to common shareholders of $65 million, or $(0.78) per diluted share, but non-GAAP earnings available for distribution of $46 million, or $0.54 per diluted common share, which supported the quarterly dividend of $0.45.
Book value per common share was $18.34, down from $19.70, with management attributing nearly two-thirds of the decline to portfolio optimization, including redeeming $1.0 billion of securitized debt at par and selling $1.2 billion of seasoned reperforming loans, releasing about $195 million for reinvestment into Agency RMBS.
The Residential Origination segment produced net income of $8 million, EBTDA of $11 million and funded production volume of $884 million, up 39% versus Q1 2025. Company-wide, earnings available for distribution were $45.8 million, total assets were $15,979,379 (dollars in thousands), GAAP leverage was 5.2:1 and recourse leverage was 2.9:1.
Chimera Investment Corporation is asking stockholders to vote at its virtual 2026 annual meeting on June 10, 2026 at 10:00 a.m. Eastern Time. Investors will elect three Class I directors through 2029, cast an advisory vote on executive compensation and ratify Ernst & Young LLP as auditor for 2026.
The record date is April 9, 2026, when 83,645,571 common shares were outstanding and entitled to one vote each. Chimera highlights its board independence, risk oversight, anti-hedging rules, stock ownership guidelines and a pay program that ties most executive compensation to return on equity, economic return and total shareholder return.
Chimera Investment Corporation is asking stockholders to vote at its virtual 2026 annual meeting on June 10, 2026 at 10:00 a.m. Eastern Time. Investors will elect three Class I directors through 2029, cast an advisory vote on executive compensation and ratify Ernst & Young LLP as auditor for 2026.
The record date is April 9, 2026, when 83,645,571 common shares were outstanding and entitled to one vote each. Chimera highlights its board independence, risk oversight, anti-hedging rules, stock ownership guidelines and a pay program that ties most executive compensation to return on equity, economic return and total shareholder return.
The Vanguard Group filed Amendment No. 12 to a Schedule 13G/A reporting its beneficial ownership of Chimera Investment Corp common stock as 0 shares, representing 0% of the class. The amendment explains an internal realignment effective January 12, 2026 that led to disaggregated reporting by subsidiaries. The filing is signed by Ashley Grim on 03/26/2026.
The Vanguard Group filed Amendment No. 12 to a Schedule 13G/A reporting its beneficial ownership of Chimera Investment Corp common stock as 0 shares, representing 0% of the class. The amendment explains an internal realignment effective January 12, 2026 that led to disaggregated reporting by subsidiaries. The filing is signed by Ashley Grim on 03/26/2026.
Chimera Investment Corporation furnished an investor presentation related to its participation in the SFVegas Conference. The presentation was made available on the company’s website in the News & Events - Presentations section.
The same SFVegas investor presentation was also furnished as Exhibit 99.1 to this report under a Regulation FD disclosure and is expressly not deemed filed for liability purposes under the Securities Exchange Act or incorporated into other securities filings unless specifically referenced.
Chimera Investment Corporation furnished an investor presentation related to its participation in the SFVegas Conference. The presentation was made available on the company’s website in the News & Events - Presentations section.
The same SFVegas investor presentation was also furnished as Exhibit 99.1 to this report under a Regulation FD disclosure and is expressly not deemed filed for liability purposes under the Securities Exchange Act or incorporated into other securities filings unless specifically referenced.
Chimera Investment Corp Chief Legal Officer and Secretary Miyun Sung reported a tax-related share disposition. On February 17, 2026, 8,165 shares of common stock were withheld at $13.70 per share to cover taxes tied to previously vested restricted stock units.
After this tax-withholding disposition, Sung directly holds 60,836 shares of Chimera common stock. Footnotes explain that dividend equivalent rights linked to restricted and performance stock units are included in this common stock balance and are economically equivalent to one share each.
Chimera Investment Corp Chief Legal Officer and Secretary Miyun Sung reported a tax-related share disposition. On February 17, 2026, 8,165 shares of common stock were withheld at $13.70 per share to cover taxes tied to previously vested restricted stock units.
After this tax-withholding disposition, Sung directly holds 60,836 shares of Chimera common stock. Footnotes explain that dividend equivalent rights linked to restricted and performance stock units are included in this common stock balance and are economically equivalent to one share each.
Chimera Investment Corp's Chief Investment Officer, Jack Lee Macdowell Jr., reported a Form 4 transaction involving a tax-related share disposition. A total of 12,200 shares of common stock were withheld at a price of $13.70 per share to cover taxes tied to previously granted restricted stock units that vested.
After this tax-withholding disposition, Macdowell directly holds 302,421 shares of Chimera common stock. Footnotes clarify that dividend equivalent rights on RSUs and performance stock units are included in his reported common stock balance, with each right economically equivalent to one share.
Chimera Investment Corp's Chief Investment Officer, Jack Lee Macdowell Jr., reported a Form 4 transaction involving a tax-related share disposition. A total of 12,200 shares of common stock were withheld at a price of $13.70 per share to cover taxes tied to previously granted restricted stock units that vested.
After this tax-withholding disposition, Macdowell directly holds 302,421 shares of Chimera common stock. Footnotes clarify that dividend equivalent rights on RSUs and performance stock units are included in his reported common stock balance, with each right economically equivalent to one share.
Chimera Investment Corp’s Chief Financial Officer, Viswanathan Subramaniam, reported a tax-related share disposition. On February 17, 2026, he disposed of 51,800 shares of common stock at $13.70 per share through a transaction classified as a tax-withholding disposition.
According to the footnotes, these shares were withheld to pay taxes tied to the vesting of earlier performance stock unit (PSU) and restricted stock unit (RSU) awards. After this withholding, his directly held common stock balance was 200,507 shares. The filing also notes that dividend equivalent rights on RSUs and PSUs are included in this common stock balance.
Chimera Investment Corp’s Chief Financial Officer, Viswanathan Subramaniam, reported a tax-related share disposition. On February 17, 2026, he disposed of 51,800 shares of common stock at $13.70 per share through a transaction classified as a tax-withholding disposition.
According to the footnotes, these shares were withheld to pay taxes tied to the vesting of earlier performance stock unit (PSU) and restricted stock unit (RSU) awards. After this withholding, his directly held common stock balance was 200,507 shares. The filing also notes that dividend equivalent rights on RSUs and PSUs are included in this common stock balance.
Chimera Investment Corp president and CEO Phillip John Kardis II reported a tax-related share disposition tied to equity awards. On February 17, 2026, 127,168 shares of common stock were withheld at $13.70 per share to cover taxes on vesting performance and restricted stock units.
After this withholding, his directly held common stock balance is 579,085 shares. Footnotes explain that dividend equivalent rights on these units are included in his common stock holdings, and that each right is economically equivalent to one share of Chimera common stock.
Chimera Investment Corp president and CEO Phillip John Kardis II reported a tax-related share disposition tied to equity awards. On February 17, 2026, 127,168 shares of common stock were withheld at $13.70 per share to cover taxes on vesting performance and restricted stock units.
After this withholding, his directly held common stock balance is 579,085 shares. Footnotes explain that dividend equivalent rights on these units are included in his common stock holdings, and that each right is economically equivalent to one share of Chimera common stock.